ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS
News

Helsinki/ Langen­feld — Labqua­lity Oy acqui­res P.R.I.S.M.A.-CRO Clini­cal Rese­arch Orga­niza­tion. P.R.I.S.M.A. is a German company specia­li­zing in clini­cal trial services for the phar­maceu­ti­cal and biotech indus­tries. P.R.I.S.M.A. and its expe­ri­en­ced profes­sio­nals streng­then Labquality’s offer of clini­cal trials in the phar­maceu­ti­cal and biotech markets. The acqui­si­tion is in line with Labquality’s stra­tegy to build a full-service inter­na­tio­nal contract rese­arch orga­niza­tion (CRO). — A team led by Dr. Jörg Schewe, Heuking Part­ner at the Hamburg office, advi­sed Finnish Labqua­lity Oy on the acqui­si­tion of P.R.I.S.M.A.-CRO Clini­cal Rese­arch Orga­ni­sa­tion GmbH.

Labqua­lity Oy is a Finnish company based in Helsinki. The team consists of health­care and health tech quality experts. Labqua­lity provi­des quality services to the health­care, phar­maceu­ti­cal and medi­cal device indus­tries; these include exter­nal quality assess­ments, regu­la­tory consul­ting, clini­cal trials and studies, audits and certi­fi­ca­ti­ons, and trai­ning. Labqua­lity supports medi­cal device and in vitro diagno­stic manu­fac­tu­r­ers, phar­maceu­ti­cal compa­nies, health­care faci­li­ties, and clini­cal labo­ra­to­ries, among others.

The acqui­si­tion of P.R.I.S.M.A. enables Labqua­lity to expand its CRO busi­ness in the Euro­pean phar­maceu­ti­cal market. This expands Labquality’s clini­cal trial services to phar­maceu­ti­cals in Germany and streng­thens its posi­tion as a CRO service provi­der for the phar­maceu­ti­cal and health­care tech­no­logy indus­try.

Advi­sor Labqua­lity Oy: Heuking Kühn Lüer Wojtek

Dr. Jörg Schewe (lead), Caro­line Frohn­wie­ser (photo © Heuking), both Hamburg,
Sebas­tian Poll­meier (all M&A /Corporate), Düsseldorf,
Dr. Henrik Lay, Simon Pommer, LL.M. (both tax law), both Hamburg,
Dr. Lutz Keppe­ler (Infor­ma­tion Tech­no­logy & Tele­com­mu­ni­ca­ti­ons), Cologne,
Dr. Andreas Walle, Theresa Arndt, LL.M. (both Labor Law), Larissa Krebs (Corpo­rate / Finance), all Hamburg,
Michael Kuska, LL.M., LL.M. (Infor­ma­tion Tech­no­logy & Tele­com­mu­ni­ca­ti­ons, GDPR), Julian Rosen­feld (GDPR), both Düsseldorf,
Cata­rina Ange­lika Seemann, LL.M. (Regu­la­tory / Health Care & Life Scien­ces), Munich

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de